drugset / Trial / NCT00737867

Vinorelbine/Gemcitabine Versus Vinorelbine/Carboplatin in Advanced Non-small Cell Lung Cancer

NCT00737867

Phase 3 Completed 444 enrolled The Norwegian Lung Cancer Study Group
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to explore if the combination of vinorelbine and gemcitabine is better than vinorelbine and carboplatin in the treatment of advanced non-small cell lung cancer, in terms of survival, quality of life and need for palliative radiotherapy.

Timeline

Start
2007-09
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboplatin Small molecule 5 unknown
Subject Gemcitabine Small molecule 1000 mg/m2
Comparator Vinorelbine Small molecule 60 mg/m2 Oral